This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Affirm Holdings (AFRM) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
AFRMPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Garmin (GRMN) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
GRMNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Kura Sushi (KRUS): Can Its 4.4% Jump Turn into More Strength?
by Zacks Equity Research
Kura Sushi (KRUS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
KRUSPositive Net Change PBPBPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Paragon 28, Inc. (FNA) Stock Jumps 7.2%: Will It Continue to Soar?
by Zacks Equity Research
Paragon 28, Inc. (FNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
VCYTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Tarsus Pharmaceuticals (TARS) Surges 10.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Tarsus Pharmaceuticals (TARS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TARSPositive Net Change SEERNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Si-Bone (SIBN): Can Its 6.9% Jump Turn into More Strength?
by Zacks Equity Research
Si-Bone (SIBN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SIBNPositive Net Change NSPRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Stratasys (SSYS): Can Its 9.9% Jump Turn into More Strength?
by Zacks Equity Research
Stratasys (SSYS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SSYSNegative Net Change IMMRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
nLight (LASR) Soars 28.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
nLight (LASR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LASRPositive Net Change AVGOPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Allbirds, Inc. (BIRD) Surges 12.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Allbirds, Inc. (BIRD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BIRDNegative Net Change GOOSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Interactive Brokers Group, Inc. (IBKR) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
IBKRPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
EyePoint Pharmaceuticals (EYPT) Soars 27.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
EyePoint Pharmaceuticals (EYPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
EYPTPositive Net Change QGENNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Prothena (PRTA): Can Its 15.0% Jump Turn into More Strength?
by Zacks Equity Research
Prothena (PRTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PRTANegative Net Change VCELPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last?
by Zacks Equity Research
Oculis Holding AG (OCS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OCSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Integral Ad Science (IAS): Can Its 9.0% Jump Turn into More Strength?
by Zacks Equity Research
Integral Ad Science (IAS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IASNegative Net Change NCMINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Tapestry (TPR): Can Its 13.5% Jump Turn into More Strength?
by Zacks Equity Research
Tapestry (TPR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TPRPositive Net Change BIRDNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength?
by Zacks Equity Research
NeuroPace (NPCE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NPCEPositive Net Change MASINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
ImmunityBio (IBRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IBRXPositive Net Change RYTMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Choice Hotels (CHH): Can Its 7.1% Jump Turn into More Strength?
by Zacks Equity Research
Choice Hotels (CHH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CHHPositive Net Change HGVPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Colliers International (CIGI) Moves 4.8% Higher: Will This Strength Last?
by Zacks Equity Research
Colliers International (CIGI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
CIGINegative Net Change JLLPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Cushman & Wakefield (CWK) Soars 6.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Cushman & Wakefield (CWK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CWKNegative Net Change BEKENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Palo Alto Networks (PANW) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
PANWNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
CoreCard (CCRD) Moves 6.6% Higher: Will This Strength Last?
by Zacks Equity Research
CoreCard (CCRD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CCRDPositive Net Change ADTNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BlackSky Technology (BKSY) Soars 6.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
BlackSky Technology (BKSY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
BKSYPositive Net Change TTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Laird Superfood (LSF): Can Its 24.7% Jump Turn into More Strength?
by Zacks Equity Research
Laird Superfood (LSF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
LSFPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Zai Lab Limited (ZLAB) Moves 14.7% Higher: Will This Strength Last?
by Zacks Equity Research
Zai Lab Limited (ZLAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ZLABPositive Net Change ADMAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today